ABUS
Arbutus Biopharma CorpCompany with tickers: ABUS
CIK
1447028
CUSIP
03879J100
Shares Outstanding
197,537,710
13F Activity (30d)
152 filings
151 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $179,126,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $10,218,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $4,120,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $168,908,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $169,695,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $0.88 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $0.87 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |